Eli Lilly plans to expand insulin access for diabetics, NCD therapies in India
With approximately 101 million individuals living with diabetes, increasing access to insulin and advanced treatments is ...
Proficio Capital Partners LLC Acquires 1,562 Shares of Eli Lilly and Company (NYSE:LLY)
Proficio Capital Partners LLC lifted its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 30.2% in the fourth ...
Eli Lilly and Company (NYSE:LLY) Given Average Rating of “Moderate Buy” by Brokerages
Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the ...
Medical News Today18d
Humulin R interactions: Alcohol, medications, and other factors
They can tell you more about drugs that interact with Humulin R and what medications should not be taken with this insulin. Here’s a table of drugs that can interact with Humulin R. Keep in mind ...
Nasdaq25d
Where Will Eli Lilly Be in 5 Years?
It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...
The Motley Fool25d
Where Will Eli Lilly Be in 5 Years?
Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.